European Medicines Agency decides to suspend Avandia

"The European Medicines Agency has announced a recommendation to suspend Avandia (Rosiglitazone) from the European market following a review into the safety of the drug. Diabetes UK is advising anyone currently taking Avandia to consult their healthcare team without delay to discuss switching onto an alternative treatment that is best suited to their needs" - Diabetes UK